Actuate Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Actuate Therapeutics's estimated annual revenue is currently $904.5k per year.
- Actuate Therapeutics's estimated revenue per employee is $100,500
- Actuate Therapeutics's total funding is $45.7M.
Employee Data
- Actuate Therapeutics has 9 Employees.
- Actuate Therapeutics grew their employee count by 29% last year.
Actuate Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Chemistry, Manufacturing, & Controls | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Clinical Program Director | Reveal Email/Phone |
4 | Director, Clinical Development | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Project Manager, Operations and Translational Science | Reveal Email/Phone |
7 | Associate Manager, Clinical Operations | Reveal Email/Phone |
8 | Medical Monitor | Reveal Email/Phone |
Actuate Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Actuate Therapeutics?
Actuate Therapeutics, Inc. is a pharmaceuticals company based out of 1401 FOCH ST, Fort Worth, Texas, United States.
keywords:N/A
$45.7M
Total Funding
9
Number of Employees
$904.5k
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Actuate Therapeutics News
... AbGenomics International Inc, Ability Pharmaceuticals SL, Aclaris Therapeutics Inc, Actuate Therapeutics Inc, Aduro BioTech Inc.
CHICAGO and FORT WORTH, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical...
CHICAGO and FORT WORTH, Texas (PRWEB) October 28, 2021 Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced that their Phase 2 open-label single arm study of elraglusib (9-ING-41) plus gemcitabine/nab-paclitaxel treatment met its primary endpoint for ...
CHICAGO, and FORT WORTH, Texas (PRWEB) August 05, 2021 Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 9-ING-41 for treatment of patients with pancreatic can ...
Actuate Therapeutics, Inc., a Chicago, IL- and Forth Worth, TX-based clinical stage biopharmaceutical company, raised an additional $6.5M in a Series B-3 financing round. This Series B-3, which brought total funding for Actuate’s Series B round to over $28.2M, was led by Bios Partners with part ...
Other Companies in Fort Worth
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 9 | -83% | N/A |
#2 | $0.7M | 9 | 0% | N/A |
#3 | $0.7M | 9 | 13% | N/A |
#4 | $1.3M | 9 | -68% | N/A |
#5 | $0.5M | 9 | 13% | N/A |